Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2000
12/07/2000WO2000020589A9 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19924965A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2385822A1 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2376133A1 Tumor-associated antigen (c42)
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000CA2375349A1 A method for the transfer of antigens to dendritic cells
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375095A1 Groel muteins with improved stability
12/07/2000CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374897A1 Compositions of a-beta peptide and processes for producing same
12/07/2000CA2374599A1 Dr4 antibodies and uses thereof
12/07/2000CA2374402A1 Biosynthesis of foreign proteins using transformed microalgae
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2372250A1 Fimbrial proteins
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2370311A1 Prevention and treatment of amyloidogenic disease
12/06/2000EP1057895A1 Fusion protein comprising Shiga toxin 2e B subunit, (vaccine)compositions comprising it, and methods for their production
12/06/2000EP1057892A1 Attenuated mutant enteropathogenic E. coli (EPEC) strains, process for their production and their use
12/06/2000EP1057889A1 Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same
12/06/2000EP1057035A2 Method for detecting intimin producing microorganisms
12/06/2000EP1056886A1 Hla linked pre-eclampsia and miscarriage susceptibility gene
12/06/2000EP1056879A1 Self-replicating vector for dna immunization against hiv
12/06/2000EP1056878A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
12/06/2000EP1056869A2 Cell cycle related proteins
12/06/2000EP1056865A2 Leptospiral outer membrane protein, lipl32
12/06/2000EP1056860A1 High affinity humanized anti-tag-72 monoclonal antibodies
12/06/2000EP1056859A1 High affinity humanized anti-cea monoclonal antibodies
12/06/2000EP1056857A2 Transporter for saccharide-coupled medicaments
12/06/2000EP1056852A1 Anti-angiogenic vaccines: substances and methods relating thereto
12/06/2000EP1056851A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72
12/06/2000EP1056849A1 Human smn-like protein
12/06/2000EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects
12/06/2000EP1056842A2 Genetic vaccine vector engineering
12/06/2000EP1056838A1 Method for the development of an hiv vaccine
12/06/2000EP1056834A2 Apoptotic cell-mediated antigen presentation to dendritic cells
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056762A1 Genetic immunization with nonstructural proteins of hepatitis c virus
12/06/2000EP1056761A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE
12/06/2000EP1056472A2 Specific antibodies against mammary tumor-associated mucin, method for production and use
12/06/2000EP1056471A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
12/06/2000EP1056470A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
12/06/2000EP1056469A1 Novel peptide copolymer compositions
12/06/2000EP0777458B1 Control of hair growth
12/06/2000EP0675733B1 Peptide-carbohydrate conjugates generating t-cell immunity
12/06/2000CN1275918A Method and food product for increasing muscle protein and reducing fat in animals
12/06/2000CN1275917A Potentiator for antibody against lymphoid tumor
12/06/2000CN1275576A Human urine anti-tumor (antibacterial) peptide, its preparation and use
12/06/2000CN1059128C Milk powder containing specific immunity globulin and productive process thereof
12/05/2000US6156887 Compositions and methods for the treatment and diagnosis of immune disorders
12/05/2000US6156881 Inhibition of cell adhesion protein-carbohydrate interactions
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156877 Receptor for interleukin-4; has molecular weight of about 200,000 daltons; antitumor agents; immunosuppressants; antibodies
12/05/2000US6156733 Use of leukemia inhibitory factor and endothelin antagonists
12/05/2000US6156567 Truncated transcriptionally active cytomegalovirus promoters
12/05/2000US6156556 Flea protease proteins, nucleic acid molecules, and uses thereof
12/05/2000US6156541 Compositions and methods for catalyzing hydrolysis of HIV gp120
12/05/2000US6156537 Phospho-N-acetylmuramoyl-pentapeptide transferase of Streptococcus pneumoniae
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000US6156498 Establishment of HHV-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting HHV-8 infection
12/05/2000US6156495 Kit for detecting the presence of microorganism antigen in humans; for the development of vaccines against viral diseases
12/05/2000US6156319 Polypeptide
12/05/2000US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
12/05/2000US6156316 Forming human cytotoxic t-cell; contacting blood cells with peptide
12/05/2000US6156314 Monoclonal antibodies
12/05/2000US6156313 Human monoclonal antibodies to herpes simplex virus and methods therefor
12/05/2000US6156310 Isolated polypeptide
12/05/2000US6156307 Immortalization of dendritic cells with v-myc oncogene
12/05/2000US6156302 Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
12/05/2000CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
12/05/2000CA1341149C Insulin receptor
12/04/2000CA2309395A1 Methods for preventing and treating alzheimer's disease
11/2000
11/30/2000WO2000072023A2 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000071725A2 Combination neisserial compositions
11/30/2000WO2000071724A2 Novel compounds from moraxella catarrhalis
11/30/2000WO2000071720A1 Il-1 eta dna and polypeptides
11/30/2000WO2000071717A1 Secreted alpha-helical protein - 32
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071573A2 Immunogenic peptides derived from mage and the use thereof
11/30/2000WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000WO2000071556A1 Prodrug activation using catalytic antibodies
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071165A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
11/30/2000WO2000071158A1 Tagged epitope protein transposable element
11/30/2000WO2000071157A2 New vaccine formulations - 1
1 ... 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 ... 1823